Clinical Trials Directory

Trials / Completed

CompletedNCT00558792

Coronary MDCTA With Iopamidol Injection 370

A Phase II Multicenter Randomized Double Blind Dose Finding Study of Iopamidol Injection 370 in Multidetector Computed Tomographic Angiography (MDCTA) in Patients With Suspected Coronary Artery Stenosis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
210 (actual)
Sponsor
Bracco Diagnostics, Inc · Industry
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.

Conditions

Interventions

TypeNameDescription
DRUGIsovue 370, 70 mL70 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second
DRUGIsovue 370, 80 mL80 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second
DRUGIsovue 370, 90 mL90 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second

Timeline

Start date
2007-11-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2007-11-15
Last updated
2012-10-24
Results posted
2012-10-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00558792. Inclusion in this directory is not an endorsement.